ED
Global Health EDCTP3 Joint Undertaking (EDCTP3)

Global Collaboration Action for the Development of Vaccines for Reducing the Disease Burden of Tuberculosis in Sub-Saharan Africa

Funds clinical trials of TB vaccine candidates and licensed vaccines targeting adolescents, adults and vulnerable groups in sub-Saharan Africa.

ClosedGlobal Health EDCTP3 Joint Undertaking (EDCTP3)EUAlbaniaArmeniaBosnia and HerzegovinaCanadaFaroe IslandsGeorgiaIcelandIsraelKosovoMoldovaMontenegroNew ZealandNorth MacedoniaNorwaySerbiaTunisiaTรผrkiyeUkraineUnited KingdomMoroccoSouth KoreaSwitzerlandBJBFCMCICDEthiopiaSZGAGMGhanaGWGNKenyaLRMWMLMZNENigeriaCGRwandaSenegalSLSOSouth AfricaTanzaniaUgandaZMZW

Funded projects run early- or late-stage clinical studies on TB vaccine candidates and licensed vaccines in sub-Saharan Africa, aiming for at least two of three outcomes, the first of which is mandatory: evidence of a candidate's immunogenicity, efficacy, safety or clinical utility; clinical data covering adolescents, adults and where relevant pregnant women, newborns, children and people with co-โ€ฆ

This topic wants early- or late-stage clinical studies evaluating the safety, immunogenicity, efficacy or clinical utility of tuberculosis vaccine candidates and licensed vaccines in sub-Saharan Africa, primarily in adolescents and adults, and where relevant pregnant women, newborns, children and people with co-infections. It excludes implementation research, and expects proposals to build on the Global TB Vaccine R&D roadmap and consider WHO product-profile and evidence frameworks.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.โ‚ฌ45.9M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides โ†’
European Commission logo
Scheduled

Clinical trials for advancing innovative interventions for neurodegenerative diseases

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.

MedtechBiotech
โ‚ฌ10MApr'27
Department for Science, Innovation and Technology logo
Open

Life Sciences Transformational R&D Investment Fund (TRIF) Pilot

๐Ÿ‡ฌ๐Ÿ‡งDSIT ยท United Kingdom

Capital grants for large-scale UK life sciences R&D investments.

BiotechMedtech+1
ยฃ5M โ€“ ยฃ25MApr'28
European Commission logo
Scheduled

Personalised approaches to reduce risks from adverse drug reactions due to multiple medications

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds safer medication management using biomarkers, clinical data and decision support.

MedtechBiotech+1
โ‚ฌ8M โ€“ โ‚ฌ10MApr'27
European Commission logo
Scheduled

Mission Soil and Cancer: Living Labs for Carcinogenic Contamination

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds two โ‚ฌ12M projects using living labs to remediate carcinogenic soils and trace cancer risks through people, food, water and air.

Climate TechMedtech+2
โ‚ฌ12MSep'27
European Commission logo
Scheduled

Horizon Health: Bio-printing for Regenerative Medicine

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds โ‚ฌ7โ€“10M projects that advance living-cell bio-printing from laboratory proof toward regenerative medicine.

BiotechMedtech
โ‚ฌ7M โ€“ โ‚ฌ10MSep'27
European Commission logo
Scheduled

Clinical Research for Common Cancers

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds โ‚ฌ7โ€“10M programmes that bring better cancer diagnosis and treatment trials to patients across four or more European countries.

MedtechBiotech+1
โ‚ฌ7M โ€“ โ‚ฌ10MSep'27